Surgery, Gastroenterology and Oncology
Vol. 23, No. 2, Apr 2018
A Study of Incidence and Significance of Intraoperative Peritoneal fluid Fungal Culture in Patients with Perforated Peptic Ulcers
Mahim Koshariya, Surabhi Garg, Anshul Siroliya, Abhishek Shitole, Rakesh Pandey, Amit Katlana, Arvind Rai
ORIGINAL PAPER, Apr 2018
Article DOI: 10.21614/sgo-23-2-142
Background: Although the incidence of peptic ulcer disease has reduced, the peptic ulcer perforation rates remain constant. Till recently the emphasis has been placed on the identification of microbial flora associated with peritonitis caused by perforated peptic ulcer.
The aim of this study was to determine the incidence and significance of intraoperative peritoneal fluid culture of fungus in patients with perforated peptic ulcers.

Materials and method: In this study, we included 53 patients with intraoperatively confirmed perforated gastroduodenal ulcers admitted in our hospital. Patients were evaluated pre-operatively; intra-operative peritoneal fluid specimen was sent for culture & sensitivity; post-operative records of various parameters were studied; patient morbidity and mortality were evaluated with reference to their culture outcome.

Results: Fungal cultures of peritoneal fluid were positive in 24 out of 53 patients (45.2%), Candida being the most common isolated species in 22 patients (91.6%), followed by Apergillus. Fungal cultures were found positive more commonly in patients above 50 years of age and in females. Age, preoperative organ failure, delay in operation, high Mannheim Peritonitis Index (MPI) and Acute Physiology And Chronic Health Evaluation (APACHE) II scores, smoking, alcohol abuse, steroid use, H2 blockers and preoperative antibiotic therapy were risk factors for a positive fungal culture. MPI of 20 or more was statistically significant (p<0.001). Increased morbidity was observed in fungal peritonitis patients in comparison to non-fungal peritonitis cases. The Candida peritonitis group had a mortality of 18.18%, while the mortality in the non- Candida peritonitis group was 3.44%.

Conclusion: Fungal positivity was a significant risk factor for adverse outcome in patients with a PPU. Patients with associated risk factors and a MPI score >24 and APACHE II score of >12 with positive intra-operative peritoneal fluid fungal culture can be considered for early antifungal treatment.

Full Text Sources: Download pdf
Abstract:   Abstract EN
Views: 3136


Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Dec 2025

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2025
Meetings and Courses in 2024
Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/
Publisher’s Note:
The opinions, statements, and data contained in article are solely those of the authors and not of Surgery, Gastroenterology and Oncology journal or the editors. Publisher and the editors disclaim responsibility for any damage resulting from any ideas, instructions, methods, or products referred to in the content.